0001415889-24-002936.txt : 20240207
0001415889-24-002936.hdr.sgml : 20240207
20240207163806
ACCESSION NUMBER: 0001415889-24-002936
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240206
FILED AS OF DATE: 20240207
DATE AS OF CHANGE: 20240207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Savitz Adam
CENTRAL INDEX KEY: 0002008707
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41944
FILM NUMBER: 24604863
MAIL ADDRESS:
STREET 1: C/O ALTO NEUROSCIENCE, INC.
STREET 2: 369 SOUTH SAN ANTONIO ROAD
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alto Neuroscience, Inc.
CENTRAL INDEX KEY: 0001999480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 834210124
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 369 SOUTH SAN ANTONIO RD.
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 773-255-5012
MAIL ADDRESS:
STREET 1: 369 SOUTH SAN ANTONIO RD.
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
4
1
form4-02072024_090257.xml
X0508
4
2024-02-06
0001999480
Alto Neuroscience, Inc.
ANRO
0002008707
Savitz Adam
C/O ALTO NEUROSCIENCE, INC.
369 SOUTH SAN ANTONIO ROAD
LOS ALTOS
CA
94022
false
true
false
false
CHIEF MEDICAL OFFICER
0
Common Stock
2024-02-06
4
C
0
7851
A
7851
I
By Trust
Common Stock
2024-02-06
4
P
0
17000
16
A
24851
I
By Trust
Series B Preferred Stock
2024-02-06
4
C
0
16666
0
D
Common Stock
7851
0
I
By Trust
Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date.
The shares are directly held by Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz (the "Friedman Trust"). The spouse of the Reporting Person is the beneficiary of the Friedman Trust, and the Reporting Person may be deemed to share beneficial ownership of the securities held by the Friedman Trust.
/s/ Erin R. McQuade, Attorney-in-Fact
2024-02-07